A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma
Status:
Completed
Trial end date:
2018-05-31
Target enrollment:
Participant gender:
Summary
This is an open-label, multicenter, phase 1/2 study of BBI608 in combination with pemetrexed
and cisplatin chemotherapy as a 1st line treatment for Malignant Pleural Mesothelioma (MPM).